Amir Bashkin
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
-
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
- Natural Antidiabetic Agents Studies
Papers in
-
- Diabetes Treatment and Management 4
- Thyroid Disorders and Treatments 4
- Natural Antidiabetic Agents Studies 1
-
- Chronic Kidney Disease and Diabetes 4
- Co-authors
- Ori Elkayam (1 shared paper)Michal Mandelboim (1 shared paper)Ella Mendelson (1 shared paper)Daphna Paran (1 shared paper)Irena Wigler (1 shared paper)Dan Caspi (1 shared paper)Irena Litinsky (1 shared paper)David Levartovsky (1 shared paper)
- Journals
- Diabetes Care (2 papers)JAMA Cardiology (2 papers)The Lancet (1 paper)American Journal of Hematology (1 paper)World Journal of Diabetes (1 paper)
- Partner nations
- IsraelUnited States
In The Last Decade
Amir Bashkin
18 papers receiving 630 citations
Amir Bashkin's Hit Papers
Peers
Comparison fields: 5 of 49
- Nephrology 209
- Endocrinology, Diabetes and Metabolism 140
- Cardiology and Cardiovascular Medicine 154
- Rheumatology 69
- Physiology 45
Countries citing papers authored by Amir Bashkin
This map shows the geographic impact of Amir Bashkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Bashkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Bashkin more than expected).
Fields of papers citing papers by Amir Bashkin
This network shows the impact of papers produced by Amir Bashkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Bashkin. The network helps show where Amir Bashkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Amir Bashkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Hit paper breakdown → | 2022 | 170 |
| 2 | 2019 | 160 | |
| 3 | 2009 | 119 | |
| 4 | 2023 | 64 | |
| 5 | 2004 | 31 | |
| 6 | 2020 | 26 | |
| 7 | 2021 | 26 | |
| 8 | 2004 | 17 | |
| 9 | 2020 | 17 | |
| 10 | 2018 | 11 | |
| 11 | 2021 | 6 | |
| 12 | 2025 | 4 | |
| 13 | 2020 | 3 | |
| 14 | 2025 | 3 | |
| 15 | 2026 | 2 | |
| 16 | 2026 | 2 | |
| 17 | [THE CLINICAL APPROACH TO DIAGNOSIS AND TREATMENT OF HYPOTHYROIDISM]. | 2017 | 1 |
| 18 | 2022 | 1 | |
| 19 | 2025 | 0 |
About Amir Bashkin
Amir Bashkin is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Physiology, Oncology and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 663 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (4 papers), Diabetes Treatment and Management (4 papers), Thyroid Disorders and Treatments (4 papers), Lysosomal Storage Disorders Research (2 papers), COVID-19 Clinical Research Studies (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Influenza Virus Research Studies (1 paper) and Natural Antidiabetic Agents Studies (1 paper). The work is most often cited by research in Nephrology (209 citations), Endocrinology, Diabetes and Metabolism (140 citations), Cardiology and Cardiovascular Medicine (154 citations), Rheumatology (69 citations) and Physiology (45 citations). Amir Bashkin has collaborated with scholars based in Israel and United States. Frequent co-authors include Ori Elkayam, Michal Mandelboim, Ella Mendelson, Daphna Paran, Irena Wigler, Dan Caspi, Irena Litinsky, David Levartovsky, Deborah Elstein and Rola Khamisy‐Farah. Their work appears in journals such as Diabetes Care, JAMA Cardiology, The Lancet, American Journal of Hematology and World Journal of Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.